LTR Pharma Limited (AU:LTP) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
LTR Pharma Limited has announced the issuance of 300,000 new options set to expire on December 2, 2028. These unquoted securities are part of an employee incentive scheme and will not be listed on the ASX. This move reflects the company’s strategy to incentivize its workforce and potentially strengthen its market position.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue